Page last updated: 2024-08-24

fluorodeoxyglucose f18 and ceritinib

fluorodeoxyglucose f18 has been researched along with ceritinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dejust, S; Fabre, G; Morland, D; Papathanassiou, D; Prevost, A	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and ceritinib

Article	Year
18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrimidines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sulfones	2016

Article

Year

18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer.

Clinical nuclear medicine, 2016, Volume: 41, Issue:11

Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrimidines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sulfones

2016